Clinical trial
The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)
NCT05882903 is registered in ClinicalTrials.gov with Oticara Australia PTY LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)
- Lead sponsor
- Oticara Australia PTY LTD
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 17, 2023
- Completion date
- June 1, 2025
- Enrollment
- 24 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis (diagnosis)